Methylation and Loss of Estrogen Receptor in Breast Cancer Cells
Author Information
Author(s): Z Chen, A Ko, J Yang, VC Jordan
Primary Institution: Robert H Lurie Cancer Center, Northwestern University Medical School
Hypothesis
Is methylation of the CpG island the fundamental mechanism responsible for the loss of estrogen receptor expression in breast cancer cells?
Conclusion
The study found that the loss of estrogen receptor expression in breast cancer cells does not require methylation of the CpG island.
Supporting Evidence
- The ER CpG island in C4:2 cells remains unmethylated.
- The loss of ER in the cell line must be due to mechanisms other than methylation.
- Methylation patterns varied among different breast cancer cell lines.
Takeaway
This study shows that breast cancer cells can lose their estrogen receptors without the DNA being methylated, which is different from what was previously thought.
Methodology
The study used in vitro cell lines derived from human breast cancer to analyze the methylation status of the estrogen receptor CpG island.
Limitations
The study does not rule out the possibility that methylation can occur in other cells or as a subsequent event after the loss of expression.
Want to read the original?
Access the complete publication on the publisher's website